"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.

Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.

Cytokinetics announced positive results from a new clinical trial comparing aficamten monotherapy to the beta blocker metoprolol.

The diagnostic yield of the exam, however, has remained largely unchanged, prompting experts to question whether CT pulmonary angiography is being overused in the ED.

The new 1.5T MRI scanner includes a wide bore and key AI features designed to boost the patient experience.

When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks.